PTGX Annual Cash & Cash Equivalents
$186.73 M
+$60.98 M+48.50%
31 December 2023
Summary:
As of January 22, 2025, PTGX annual cash & cash equivalents is $186.73 million, with the most recent change of +$60.98 million (+48.50%) on December 31, 2023. During the last 3 years, it has risen by +$69.37 million (+59.11%). PTGX annual cash & cash equivalents is now at all-time high.PTGX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Quarterly Cash And Cash Equivalents
$131.12 M
-$224.52 M-63.13%
30 September 2024
Summary:
As of January 22, 2025, PTGX quarterly cash and cash equivalents is $131.12 million, with the most recent change of -$224.52 million (-63.13%) on September 30, 2024. Over the past year, it has dropped by -$224.52 million (-63.13%). PTGX quarterly cash and cash equivalents is now -63.13% below its all-time high of $355.64 million, reached on June 30, 2024.PTGX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.5% | -63.1% |
| 3 y3 years | +59.1% | -63.1% |
| 5 y5 years | +127.1% | -63.1% |
PTGX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.0% | -63.1% | +33.1% |
| 5 y | 5-year | at high | +465.7% | -63.1% | +297.3% |
| alltime | all time | at high | +4504.9% | -63.1% | +3133.6% |
Protagonist Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $131.12 M(-63.1%) |
| June 2024 | - | $355.64 M(+106.1%) |
| Mar 2024 | - | $172.57 M(-7.6%) |
| Dec 2023 | $186.73 M(+48.5%) | $186.73 M(-19.0%) |
| Sept 2023 | - | $230.53 M(-2.1%) |
| June 2023 | - | $235.38 M(+84.3%) |
| Mar 2023 | - | $127.69 M(+1.5%) |
| Dec 2022 | $125.74 M(+1.7%) | $125.74 M(-17.7%) |
| Sept 2022 | - | $152.82 M(+27.1%) |
| June 2022 | - | $120.24 M(+22.1%) |
| Mar 2022 | - | $98.48 M(-20.4%) |
| Dec 2021 | $123.67 M(+5.4%) | $123.67 M(+2.6%) |
| Sept 2021 | - | $120.54 M(-37.4%) |
| June 2021 | - | $192.41 M(+131.8%) |
| Mar 2021 | - | $83.00 M(-29.3%) |
| Dec 2020 | $117.36 M | $117.36 M(+40.3%) |
| Sept 2020 | - | $83.63 M(-42.8%) |
| June 2020 | - | $146.24 M(+142.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $60.22 M(+82.4%) |
| Dec 2019 | $33.01 M(-59.9%) | $33.01 M(-34.2%) |
| Sept 2019 | - | $50.20 M(-29.4%) |
| June 2019 | - | $71.14 M(+1.5%) |
| Mar 2019 | - | $70.08 M(-14.8%) |
| Dec 2018 | $82.23 M(-22.4%) | $82.23 M(-5.9%) |
| Sept 2018 | - | $87.43 M(+36.9%) |
| June 2018 | - | $63.86 M(-8.2%) |
| Mar 2018 | - | $69.58 M(-34.4%) |
| Dec 2017 | $106.03 M(+402.9%) | $106.03 M(+110.4%) |
| Sept 2017 | - | $50.40 M(+386.2%) |
| June 2017 | - | $10.37 M(+8.9%) |
| Mar 2017 | - | $9.52 M(-54.9%) |
| Dec 2016 | $21.08 M(+420.0%) | $21.08 M(-78.0%) |
| Sept 2016 | - | $96.02 M(+597.4%) |
| June 2016 | - | $13.77 M(-51.9%) |
| Mar 2016 | - | $28.63 M(+606.0%) |
| Dec 2015 | $4.05 M(-56.5%) | $4.05 M |
| Dec 2014 | $9.32 M | - |
FAQ
- What is Protagonist Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual cash & cash equivalents year-on-year change?
- What is Protagonist Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Protagonist Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PTGX is $186.73 M
What is the all time high annual cash & cash equivalents for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual cash & cash equivalents is $186.73 M
What is Protagonist Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, PTGX annual cash & cash equivalents has changed by +$60.98 M (+48.50%)
What is Protagonist Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PTGX is $131.12 M
What is the all time high quarterly cash and cash equivalents for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly cash and cash equivalents is $355.64 M
What is Protagonist Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PTGX quarterly cash and cash equivalents has changed by -$224.52 M (-63.13%)